| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/02/1992 | CA1302266C Formulations containing unsaturated fatty acids for the synthesis of prostaglandins and hydroxy-fatty acids in biological systems |
| 06/02/1992 | CA1302253C Use of tin protoporphyrin and tin mesoporphyrin in the treatment of psoriasis |
| 05/31/1992 | CA2056661A1 Protein and preparation thereof |
| 05/31/1992 | CA2056513A1 A controlled-release pharmaceutical preparation for intra-ocular implant |
| 05/29/1992 | WO1992008737A1 NEW HUMAN RECOMBINANT η INTERFERON |
| 05/29/1992 | WO1992008701A1 Retroviral protease inhibitors |
| 05/29/1992 | WO1992008699A1 Retroviral protease inhibitors |
| 05/29/1992 | WO1992008698A1 Retroviral protease inhibitors |
| 05/29/1992 | WO1992008694A1 Aminosulfonyl urea acat inhibitors |
| 05/29/1992 | WO1992008693A1 Aminosulfonyl carbamates |
| 05/29/1992 | WO1992008688A1 Retroviral protease inhibitors |
| 05/29/1992 | WO1992008480A1 A β-TYPE TRANSFORMING GROWTH FACTOR |
| 05/29/1992 | CA2096441A1 Heterodimer of b-type transforming growth factors 2 and 3 |
| 05/29/1992 | CA2094807A1 Aminosulfonyl carbamates |
| 05/28/1992 | WO1992009286A1 Composition containing antihistamine h2 receptor antagonists and bioadhesive material |
| 05/28/1992 | CA2096962A1 Composition containing antihistamine h2 receptor antagonists and bioadhesive material |
| 05/27/1992 | EP0487502A2 Pharmaceutically active aryl-substituted amine derivatives |
| 05/27/1992 | EP0487410A2 Endothelin antagonists |
| 05/27/1992 | EP0487270A2 HIV protease inhibitors having polyether substituents |
| 05/27/1992 | EP0487071A1 Condensed heterocyclic compounds, their production and use |
| 05/27/1992 | EP0486958A1 Physostigmine derivatives |
| 05/27/1992 | EP0486948A2 Retroviral protease inhibiting compounds |
| 05/27/1992 | EP0486809A2 Use of suramin against TNF-related diseases |
| 05/27/1992 | EP0486572A1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 05/27/1992 | DE4037941A1 Cyclopentanetherderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung Cyclopentanetherderivate, processes for their preparation and their pharmaceutical use |
| 05/27/1992 | CN1061413A Pharmaceutical compounds |
| 05/27/1992 | CN1061410A Substituted azoles, process for their preparation, agents containing them and their use |
| 05/27/1992 | CN1061408A Saturated hydroxyalkylquinoline acids as leukotriene antagonists |
| 05/27/1992 | CN1061407A Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
| 05/27/1992 | CN1016784B Process for preparating homodisaccharide hypoglycemic agents |
| 05/26/1992 | US5116871 Fatty acid therapy and compositions for the treatment of myalgic encephalomyelitis |
| 05/26/1992 | US5116858 Learning enhancement |
| 05/26/1992 | US5116828 Pharmaceutical composition for treatment of osteoporosis |
| 05/26/1992 | US5116573 Labelled vitamin d3 derivative and production process thereof |
| 05/26/1992 | CA1302005C Aminoacid derivatives as antihypertensives |
| 05/26/1992 | CA1301776C Compound of choline, a process for its preparation and therapeutic composition containing it |
| 05/26/1992 | CA1301753C Process for preparing histamine h_-antagonist and intermediates used in such process |
| 05/25/1992 | CA2056063A1 Aminodiol derivatives |
| 05/24/1992 | WO1992009573A2 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals |
| 05/24/1992 | CA2096848A1 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals |
| 05/22/1992 | WO1992009556A1 Improved matrix metalloprotease inhibitors |
| 05/22/1992 | WO1992009203A1 Tnf inhibitors |
| 05/22/1992 | CA2096623A1 Tnf inhibitors |
| 05/22/1992 | CA2096221A1 Matrix metalloprotease inhibitors |
| 05/22/1992 | CA2055902A1 Peptide derivatives, their preparation process, application of these new derivatives as drugs and pharmaceutical compositions containing them |
| 05/20/1992 | WO1992008985A2 Ligand-mediated immunofunctional hormone binding protein assay method |
| 05/20/1992 | EP0486478A2 Renin-inhibiting peptides |
| 05/20/1992 | EP0486385A1 Imidazole derivatives, process for their fabrication and pharmaceutical compositions containing them |
| 05/20/1992 | EP0486022A2 Naphthalene derivatives |
| 05/20/1992 | EP0485929A1 Substituted azoles, process for their preparation and their application |
| 05/20/1992 | EP0485725A1 Alpha-glucosidase inhibitor, pradimicin Q |
| 05/20/1992 | EP0485486A1 Process for disinfecting musculoskeletal tissue and tissues prepared thereby. |
| 05/20/1992 | EP0485430A1 Methods and compositions for ameliorating the symptoms of sepsis |
| 05/20/1992 | CN1061152A Ester inhibitors |
| 05/20/1992 | CA2055685A1 Hiv protease inhibitors having polyether substituents |
| 05/19/1992 | US5114966 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofurans 2-(rs)-substituted, useful as antioxidizing pharmaceutical products having mucoregulating and anti-ischemic properties |
| 05/19/1992 | US5114953 Peptides |
| 05/19/1992 | US5114949 Heterocyclic derivatives, their preparation and medicinal products containing them |
| 05/19/1992 | US5114927 Hypotensive agents and inhibiting renin |
| 05/19/1992 | US5114715 Analgesics to be administered by inhalation |
| 05/19/1992 | US5114714 Methods of use and compositions of (r)-isoflurane and (r)-desflurane |
| 05/19/1992 | CA1301181C2 Oxiranes |
| 05/17/1992 | CA2055636A1 Substituted azoles, process for their preparation, agents containing them and their use |
| 05/17/1992 | CA2055630A1 Naphthalene derivatives |
| 05/16/1992 | WO1992008709A1 Meta-substituted phenyl alanine derivatives |
| 05/16/1992 | CA2073776A1 Meta-substituted phenyl alanine derivatives |
| 05/15/1992 | CA2055325A1 Novel imidazole derivatives, process for preparing them and pharmaceutical compositions containing them |
| 05/14/1992 | WO1992007869A1 Inhibitors and substrates of thrombin |
| 05/14/1992 | WO1992007832A2 Substituted piperazines as central nervous system agents |
| 05/14/1992 | WO1992007831A1 Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
| 05/14/1992 | WO1992007578A1 Use of protective agents against reactive oxygen species |
| 05/14/1992 | WO1992004024A3 Toxic agent protective compounds, compositions and method |
| 05/14/1992 | WO1992004014A3 Regulation of neoplastic cell proliferation via a novel 5ht1a receptor |
| 05/14/1992 | WO1991016903A3 Use of purine derivatives for anesthesia, analgesia and in vivo organ preservation |
| 05/13/1992 | EP0485217A2 Hydantoin derivatives, and their use in preventing and treating diabetic complications and circulatory organ diseases |
| 05/13/1992 | EP0485111A2 The use of lipoxygenase and cyclooxygenase inhibitors as synergistic agents |
| 05/13/1992 | EP0484949A2 Ester inhibitors |
| 05/13/1992 | EP0484870A2 Prodrugs for beta-lactamase and uses thereof |
| 05/13/1992 | EP0484437A1 Renal-selective prodrugs for the treatment of hypertension |
| 05/13/1992 | EP0484380A1 Uses of interleukin-4 and method for purifying it |
| 05/12/1992 | US5112988 Intermediates for Substance P Antagonists |
| 05/12/1992 | US5112872 Antispasmodic agent |
| 05/12/1992 | US5112866 Sulfonylfluorides as intermediates, also useful in treatment of bone disorders, antisecretory, antiulcer |
| 05/12/1992 | US5112857 Hmg-coa reductase inhibitor metabolites |
| 05/12/1992 | US5112848 Furan and pyrrole containing lipoxygenase inhibiting compounds |
| 05/12/1992 | US5112844 Micelles |
| 05/12/1992 | US5112838 Treatment of schizophrenia |
| 05/12/1992 | US5112822 Gastrointestinal disorders and glaucoma treatment |
| 05/12/1992 | US5112596 A composition of a neuropharmaceutical or diagnostic agent, a bradykinin agonist to increase blood brain barrier permeability |
| 05/12/1992 | CA1300621C 3-substituted benzazepines |
| 05/12/1992 | CA1300510C Stabilized composition containing angiotensin converting enzyme |
| 05/08/1992 | WO1992008456A2 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 05/08/1992 | CA2095732A1 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 05/08/1992 | CA2054953A1 Ester inhibitors |
| 05/07/1992 | CA2055062A1 Prodrugs for beta-lactamase and uses thereof |
| 05/07/1992 | CA2054312A1 Synergistic agents |
| 05/06/1992 | WO1992007580A1 Therapeutic uses of melanin |
| 05/06/1992 | EP0484112A2 Use of lithium in the treatment or prophylaxis of Molluscum contagiosum |
| 05/06/1992 | EP0484094A2 Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use |
| 05/06/1992 | EP0484071A2 Synergism of HIV reverse transcriptase inhibitors |